Alpha Cognition Inc. (ACOG) Narxning foydaga nisbati
Yuqori patent to'siqlari va FDA ning qat'iy xavfsizlik talablari kognitiv buzilishlar sohasidagi Alpha Cognition (ACOG) ishlanmalari uchun sezilarli himoyani ta'minlaydi. Terapiya ma'lumotlarining aniqligi biomateriallarni tashish paytidagi qat'iy nazoratlar orqali kafolatlanadi. GURU.Markets dagi ushbu grafik P/E koeffitsiyenti -8.10 ekanligini ko'rsatmoqda. Biznes modeli tadqiqot va ishlanmalar (R&D) hamda ishlab chiqarishni autsorsing qilishga tayanadi, dori ishlab chiqarishni to'liq tashqi pudratchilarga topshiradi.
Alpha Cognition Inc (ACOG) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati Alpha Cognition|ACOG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Alpha Cognition Corp|ACOG - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Alpha Cognition Inc.|ACOG - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Alpha Cognition|Kritik likvidlik alphacognition.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ACOG - Kompaniyaning sof foydasi|Sof foyda prognozi Alpha Cognition|ACOG - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Alpha Cognition Corp|ACOG - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Alpha Cognition Inc.|ACOG - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Alpha Cognition|ACOG - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi alphacognition.com|ACOG - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Alpha Cognition
Kompaniyaning jamlanma tahlili:ACOG alphacognition.com
Alzheimer kasalligi terapiyasi ishlab chiquvchisi bo'lgan Alpha Cognition uchun P/E koeffitsiyenti kelajakdagi daromadlar bo'yicha bozor kutganlarini ko'rsatuvchi indikator vazifasini o'taydi. Ushbu metrika bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadi va bir dollar foydaning tannarxini belgilaydi. Narxning foydaga nisbati tendentsiyasini tahlil qilish orqali investor aktivning haddan tashqari qimmat baholanganlik darajasini baholaydi. Ushbu holatda, indikator Alpha-1062 molekulasining FDA tomonidan muvaffaqiyatli tasdiqlanishiga bo'lgan bozorning spekulyativ garovini aks ettiradi.
Raqobatdosh kompaniyalar tahlili
P/E multiplikatori biogen.com|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|Narxning foydaga nisbati RGC (Regencell Bioscience Ltd)|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACAD (ACADIA Corp) - Kapitalizatsiyaning sof foydaga nisbati|Xenon Pharmaceuticals - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati VKTX (vikingtherapeutics.com)|SUPN: P/E multiplikatori|Catalyst Pharma (CPRX) - P/E multiplikatori|Narx-foyda koeffitsiyenti DNLI|HRMY: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BHVN|Narx-foyda koeffitsiyenti amylyx.com AMLX|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|Praxis Precision Medicines Inc (PRAX) - Kapitalizatsiyaning foydaga nisbati|Anavex Corp - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti CeriBell EEG (CBLL)|prothena.com (PRTA) - Narxning foydaga nisbati|Narx-foyda multiplikatori ALEC|ANNX (Annexon) - P/E multiplikatori|Omeros Corp. (OMER) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NGNE (Neurogene Corp)|Bozor narxining sof foydaga nisbati ACIU|P/E multiplikatori VYGR (Voyager Therapeutics)|Biznesning o‘zini qoplash muddati neumoratx.com (NMRA)|SCLX - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Holdings Inc.|Cognition Therapeutics, Inc. (CGTX) - Narxning foydaga nisbati|Narx-foyda multiplikatori IKT|SAVA (Cassava Sciences, Inc.) - P/E multiplikatori|P/E multiplikatori Assertio Therapeutics|P/E multiplikatori COYA|Narx-foyda koeffitsiyenti vistagen.com VTGN|Narxning foydaga nisbati Ovid Therapeutics OVID|Acumen Pharmaceuticals, Inc (ABOS) - Kapitalizatsiyaning foydaga nisbati|CervoMed Inc. - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Alterity Therapeutics (ATHE)|clene.com (CLNN) - Narxning foydaga nisbati|Narx-foyda multiplikatori PEPG|JUNS (Jupiter Neurosciences) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Relmada Corp RLMD|Narx-foyda koeffitsiyenti ANVS (Annovis Bio, Inc.)|P/E multiplikatori gracetx.com (GRCE)|Narxning foydaga nisbati Firefly Neuroscience AIFF|Kompaniya qiymatining sof foydaga nisbati KLTO|NRSN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Reviva Pharmaceuticals, Inc.|MTVA: P/E multiplikatori|neuraxis.com (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical Technologies, Inc.|Narxning foydaga nisbati PASG|Narxning foydaga nisbati Neuphoria Therapeutics Inc. (NEUP)|NERV: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ATHA (Athira Pharma, Inc.)|Kompaniya qiymatining sof foydaga nisbati ADXN|Alzamend - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (protagenic.com) - Narx-foyda koeffitsiyenti|Pasithea Therapeutics Corp. - Kompaniya qiymatining sof foydaga nisbati|CRGT (Cortigent Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti avenuetx.com (ATXI)|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|CARA - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori CHRO (Chromocell Therapeutics Corporation)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Eliem Therapeutics, Inc.|ITCI - Narxning foydaga nisbati|LBPH (longboardpharma.com) - Narx-foyda multiplikatori|MRNS: P/E multiplikatori|NKGN - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NRBO|SAGE (Sage Therapeutics Inc) - Bozor narxining sof foydaga nisbati|P/E multiplikatori SNPX|Biznesning o‘zini qoplash muddati trevena.com|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|anewmeds.com (WENA) - Kapitalizatsiyaning foydaga nisbati|CERE - Narxning foydaga nisbati
